Ildefonso Pulido

Manuel Siurot Avenue
Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation.

Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation.

Journal: Revista espanola de cardiologia (English ed.)
Published: November 08, 2019

Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects.

Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects.

Journal: Antiviral research
Published: March 26, 2019

Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.

Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.

Journal: Antiviral research
Published: September 27, 2017

Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients.

Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients.

Journal: Viral immunology
Published: October 01, 2016

Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients.

Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients.

Journal: Antiviral research
Published: April 17, 2015

IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects.

IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects.

Journal: The Journal of infectious diseases
Published: December 11, 2012

Effect of maraviroc on HIV disease progression-related biomarkers.

Effect of maraviroc on HIV disease progression-related biomarkers.

Journal: Antimicrobial agents and chemotherapy
Published: September 06, 2012

Patients on a combined antiretroviral therapy after maraviroc clinical test show no immunovirological impairment.

Patients on a combined antiretroviral therapy after maraviroc clinical test show no immunovirological impairment.

Journal: Antiviral research
Published: May 31, 2012

T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.

T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.

Journal: The Journal of infection
Published: September 29, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026